TipRanks
Benitec Biopharma Ltd (DE:BJ9)
FRANKFURT:BJ9
Germany Market
BJ9
Benitec Biopharma
RESEARCH TOOLSreports

Benitec Biopharma (BJ9) Income Statement

0 Followers

Benitec Biopharma Income Statement

Last quarter (Q4 2026), Benitec Biopharma's total revenue was AU$0.00, a decrease of -100.00% from the same quarter last year. In Q4, Benitec Biopharma's net income was AU$-12.81M. See Benitec Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 26Jun 25Jun 24Jun 23Jun 22
Total Revenue
$ 0.00$ 0.00$ 0.00$ 75.00K$ 73.00K
Gross Profit
$ -481.00K$ -396.00K$ -343.00K$ 75.00K$ 64.00K
Operating Expenses
$ 50.71M$ 41.37M$ 22.49M$ 19.16M$ 17.92M
Depreciation and Amortization
$ 481.00K$ 396.00K$ 343.00K$ 381.00K$ 392.00K
EBITDA
$ -50.71M$ -41.37M$ -22.15M$ -18.70M$ -17.78M
Operating Income
$ -51.19M$ -41.77M$ -22.49M$ -19.08M$ -17.85M
Other Income/Expenses
$ 5.65M$ 3.85M$ 739.00K$ -481.00K$ -354.00K
Pretax Income
$ -45.55M$ -37.92M$ -21.75M$ -19.56M$ -18.21M
Net Income
$ -45.55M$ -37.92M$ -21.75M$ -19.56M$ -18.21M
Per Share Metrics
Basic EPS
$ -0.98$ -1.05$ -2.68$ -14.12$ -19.31
Diluted EPS
$ -0.98$ -1.05$ -2.68$ -14.12$ -19.31
Weighted Average Shares Outstanding
 46.56M 36.21M 10.26M 1.39M 1.92M
Weighted Average Shares Outstanding (Diluted)
 46.56M 36.21M 10.28M 1.39M 1.92M

Benitec Biopharma Earnings and Revenue History